David M. Whiley

10.0k total citations · 1 hit paper
244 papers, 6.3k citations indexed

About

David M. Whiley is a scholar working on Microbiology, Physiology and Epidemiology. According to data from OpenAlex, David M. Whiley has authored 244 papers receiving a total of 6.3k indexed citations (citations by other indexed papers that have themselves been cited), including 138 papers in Microbiology, 88 papers in Physiology and 77 papers in Epidemiology. Recurrent topics in David M. Whiley's work include Reproductive tract infections research (131 papers), Syphilis Diagnosis and Treatment (87 papers) and Bacterial Infections and Vaccines (78 papers). David M. Whiley is often cited by papers focused on Reproductive tract infections research (131 papers), Syphilis Diagnosis and Treatment (87 papers) and Bacterial Infections and Vaccines (78 papers). David M. Whiley collaborates with scholars based in Australia, United States and United Kingdom. David M. Whiley's co-authors include Theo P. Sloots, Michael D. Nissen, Stephen B. Lambert, Ian M Mackay, Monica M Lahra, John Tapsall, Seweryn Bialasiewicz, Melanie W. Syrmis, Namraj Goire and David Wang and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Nature Nanotechnology.

In The Last Decade

David M. Whiley

237 papers receiving 6.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Identification of a Novel Polyomavirus from Patients with Acute Respiratory Tract Infections

2007 503 citations Michael D. Nissen, David M. Whiley et al. profile →

Peers

Countries citing papers authored by David M. Whiley

Since Specialization

Citations

This map shows the geographic impact of David M. Whiley's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David M. Whiley with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David M. Whiley more than expected).

Fields of papers citing papers by David M. Whiley

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David M. Whiley. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David M. Whiley. The network helps show where David M. Whiley may publish in the future.

Co-authorship network of co-authors of David M. Whiley

This figure shows the co-authorship network connecting the top 25 collaborators of David M. Whiley. A scholar is included among the top collaborators of David M. Whiley based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David M. Whiley. David M. Whiley is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Evolving patterns of macrolide and fluoroquinolone resistance in Mycoplasma genitalium: an updated systematic review and meta-analysis 2025 ·The Lancet Microbe ·(unknown), Lenka A. Vodstrcil, Gerald L. Murray, Erica L. Plummer, Jørgen Skov Jensen, Magnus Unemo, Eric P. F. Chow, Nicola Low, David M. Whiley, Emma L. Sweeney, Jane S. Hocking, Jennifer Danielewski, Suzanne M. Garland, Christopher K. Fairley, Lei Zhang, Catriona S. Bradshaw, Dorothy A. Machalek	7
2	Sustained transmission over two decades of a previously unrecognised MPT64 negative Mycobacterium tuberculosis strain in Queensland, Australia: a whole genome sequencing study 2024 ·The Lancet Regional Health - Western Pacific ·Arnold Bainomugisa, Sushil Pandey, (unknown), Melanie W. Syrmis, David M. Whiley, Vitali Sintchenko, Lachlan Coin, Ben J. Marais, Christopher Coulter	3
3	A universal reagent for detection of emerging diseases using bioengineered multifunctional yeast nanofragments 2023 ·Nature Nanotechnology ·Junrong Li, Christopher B. Howard, Shuvashis Dey, Kym Lowry, David M. Whiley, Simon Puttick, Stephen Rose, Richard J. Lobb, Alain Wuethrich, Selvakumar Edwardraja, Matt Trau	17
4	Intestinal shedding of enteric agents in histo-blood group antigen-secretor children in an Australian community-based birth cohort study 2022 ·SHILAP Revista de lepidopterología ·Gabor Mihala, Robert S. Ware, Catherine Cheung, Stephen B. Lambert, Peter D. Sly, David M. Whiley, Keith Grimwood	1
5	An Observational Study to Assess the Effectiveness of 4CMenB against Meningococcal Disease and Carriage and Gonorrhea in Adolescents in the Northern Territory, Australia—Study Protocol 2022 ·Vaccines ·Helen Marshall, Prabha H. Andraweera, James Ward, John Kaldor, Ross Andrews, Kristine Macartney, Peter Richmond, Vicki Krause, Ann P. Koehler, David M. Whiley, Lynne Giles, (unknown), (unknown), Jonathan Karnon, Rob Baird, Andrew J. Lawrence, Helen Petousis‐Harris, Philippe De Wals, (unknown), Michael Binks, Lisa J Whop	7
6	SARS-CoV-2 RT-PCR to Screen for B.1.617.2 (Delta) Variant of Concern 2022 ·Diagnostics ·Kym Lowry, Claire Wang, (unknown), Cameron Buckley, Steven G. Badman, Patrick N. A. Harris, Ian M Mackay, David M. Whiley	2
7	Histo-blood group antigens and rotavirus vaccine virus shedding in Australian infants 2022 ·Pathology ·Asmaa El‐Heneidy, Catherine Cheung, Stephen B. Lambert, Claire Wang, David M. Whiley, Peter D. Sly, Robert S. Ware, Keith Grimwood	3
8	Molecular characterisation of Neisseria gonorrhoeae associated with disseminated gonococcal infections in Queensland, Australia: a retrospective surveillance study 2022 ·BMJ Open ·(unknown), Sumeet Sandhu, Colleen L. Lau, (unknown), Ella Trembizki, David M. Whiley, Amy V. Jennison	2
9	parC Variants in Mycoplasma genitalium: Trends over Time and Association with Moxifloxacin Failure 2022 ·Antimicrobial Agents and Chemotherapy ·Gerald L. Murray, Kaveesha Bodiyabadu, Lenka A. Vodstrcil, Dorothy A. Machalek, Jennifer Danielewski, Erica L. Plummer, Suzanne M. Garland, David M. Whiley, Emma L. Sweeney, Catriona S. Bradshaw	30
10	Potentially Pathogenic Organisms in Stools and Their Association With Acute Diarrheal Illness in Children Aged <2 Years 2021 ·Journal of the Pediatric Infectious Diseases Society ·Gabor Mihala, Robert S. Ware, Stephen B. Lambert, Seweryn Bialasiewicz, David M. Whiley, Mohinder Sarna, Theo P. Sloots, Michael D. Nissen, Keith Grimwood	6
11	MicroPIPE: validating an end-to-end workflow for high-quality complete bacterial genome construction 2021 ·BMC Genomics ·Valentine Murigneux, Leah W. Roberts, Brian M. Forde, Minh‐Duy Phan, Nguyen Thi Khanh Nhu, Adam Irwin, Patrick N. A. Harris, David L. Paterson, Mark A. Schembri, David M. Whiley, Scott A. Beatson	26
12	Modelling response strategies for controlling gonorrhoea outbreaks in men who have sex with men in Australia 2021 ·PLoS Computational Biology ·Qibin Duan, Christopher Carmody, Basil Donovan, Rebecca Guy, (unknown), John Kaldor, Monica M Lahra, Matthew Law, David A. Lewis, Michael Maley, Skye McGregor, Anna McNulty, Christine Selvey, David J. Templeton, David M. Whiley, David G. Regan, James Wood	5
13	Evaluation of Commercially Available Viral Transport Medium (VTM) for SARS-CoV-2 Inactivation and Use in Point-of-Care (POC) Testing 2020 ·Viruses ·David van Bockel, C. Mee Ling Munier, Stuart Turville, Steven G. Badman, Gregory J. Walker, Alberto Ospina Stella, Anupriya Aggarwal, Malinna Yeang, (unknown), Anthony D. Kelleher, Tanya Applegate, Andrew Vallely, David M. Whiley, William D. Rawlinson, Philip Cunningham, John Kaldor, Rebecca Guy	29
14	Young Aboriginal people’s sexual health risk reduction strategies: a qualitative study in remote Australia 2020 ·Sexual Health ·Stephen Bell, James Ward, Peter Aggleton, (unknown), Bronwyn Silver, (unknown), (unknown), Christopher K. Fairley, David M. Whiley, Nathan Ryder, Basil Donovan, Rebecca Guy, John Kaldor, Lisa Maher	12
15	The Australian Gonococcal Surveillance Programme 1979–2017 2017 ·Microbiology Australia ·Monica M Lahra, C. R. Robert George, David M. Whiley	6
16	Effectiveness of a cough management algorithm at the transitional phase from acute to chronic cough in Australian children aged <15 years: protocol for a randomised controlled trial 2017 ·BMJ Open ·Kerry-Ann O’Grady, Keith Grimwood, Maree Toombs, Theo P. Sloots, Michael Otim, David M. Whiley, (unknown), (unknown), Paul J. Torzillo, Helen Buntain, (unknown), (unknown), (unknown), Anne B. Chang	11
17	Public health implications of molecular point-of-care testing for chlamydia and gonorrhoea in remote primary care services in Australia: a qualitative study 2015 ·BMJ Open ·Lisa Natoli, Rebecca Guy, Mark Shephard, David M. Whiley, Sepehr N. Tabrizi, James Ward, David G. Regan, Steven G. Badman, David A. Anderson, John Kaldor, Lisa Maher	19
18	Molecular approaches to enhance surveillance of gonococcal antimicrobial resistance 2014 ·Nature Reviews Microbiology ·Namraj Goire, Monica M Lahra, Marcus Y. Chen, Basil Donovan, Christopher K. Fairley, Rebecca Guy, John Kaldor, David G. Regan, James Ward, Michael D. Nissen, Theo P. Sloots, David M. Whiley	81
19	Nucleic Acid Amplification Testing for Neisseria gonorrhoeae 2006 ·Journal of Molecular Diagnostics ·David M. Whiley, John Tapsall, Theo P. Sloots	137
20	Detection of Influenza type A virus by LightCycler RT-PCR 2003 ·Queensland's institutional digital repository (The University of Queensland) ·David M. Whiley, Melanie W. Syrmis, Ian M Mackay, Theo P. Sloots	2

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact